CMFRI's Natural product from seaweeds to combat fatty liver disease set to hit market Manorama Online dated 20th December 2022

CMFRI, Library (2022) CMFRI's Natural product from seaweeds to combat fatty liver disease set to hit market Manorama Online dated 20th December 2022. Manorama Online.

Text Manorama online_20-12-2022.pdf Download (153kB)

Abstract

The Central Marine Fisheries Research Institute (CMFRI) has signed an MoU for the production of Cadalmin LivCure extract, a patent-protected nutraceutical product from seaweeds, to combat non-alcoholic fatty liver disease (NAFLD). A Memorandum of Understanding (MoU) was inked with Emineotech, a private limited company dealing with health products, for commercial production and marketing, said CMFRI.

Actions (login required)

View Item